SEC Tracker
Get the app
Person · CIK 2061851

Jennifer Fitzpatrick

CLO and Head of Program Mgmt. at Sionna Therapeutics

Source: Forms 3, 4, 5 and 144 on SEC EDGAR

Sold on Form 4$1.4M
Noticed on Form 144$1.5M
Bought on Form 4$0
Companies1

Holdings now

As reported after the latest Form 3, 4 or 5 at each company.

How these figures work

Options and RSUs are from the latest filing that lists them; earlier grants may also be held. Holdings can be out of date when a person stops filing.

CompanySecurityHeldShares or unitsAs of
Sionna Therapeutics SIONCommon StockDirectly56,265Sep 17, 2026 · Filing · EDGAR
Sionna Therapeutics SIONNon-Qualified Stock Option (right to buy)
exercise $7.18, expires Jan 1, 2036, into Common Stock
Directly103,140Sep 17, 2026 · Filing · EDGAR

Sold and noticed by quarter

Jennifer Fitzpatrick: dollars sold on Form 4 and noticed on Form 144 per quarter, Q1 2025 to Q4 2026$451K$0Q1 2025: $0 noticed on Form 144Q1 2025: $0 sold on Form 4Q2 2025: $0 noticed on Form 144Q2 2025: $0 sold on Form 4Q3 2025: $252K noticed on Form 144Q3 2025: $237K sold on Form 4Q4 2025: $419K noticed on Form 144Q4 2025: $415K sold on Form 4Q1 2026: $354K noticed on Form 144Q1 2026: $347K sold on Form 4Q2 2026: $0 noticed on Form 144Q2 2026: $0 sold on Form 4Q3 2026: $451K noticed on Form 144Q3 2026: $447K sold on Form 4Q4 2026: $0 noticed on Form 144Q4 2026: $0 sold on Form 4Q1 2025Q3 2025Q1 2026Q3 2026

Sold (Form 4) Noticed (Form 144) Bought (Form 4)

Quarterly totals as a table
QuarterSold (Form 4)Noticed (Form 144)
Q3 2026$447K$451K
Q1 2026$347K$354K
Q4 2025$415K$419K
Q3 2025$237K$252K

Planned sales (Form 144) and the sales that followed

Each Form 144 notice of a planned sale, grouped by broker and 10b5-1 plan, with the Form 4 sales we matched to it.

How we match

A Form 144 is a notice of a planned sale by an affiliate. SEC Tracker matches each notice to Form 4 sales by the same person at the same company within 90 days of the notice, up to the shares noticed. The match is our inference, not something either filing states.

Notice dateNoticedPlanned saleOutcomeLinks
Sionna Therapeutics SION · Morgan Stanley Smith Barney · 10b5-1 plan adopted Jun 5, 2025 · 4 notices
Jul 6, 202610,250 · ~$451KJul 6, 2026Sold as noticed Sold 10,250 at $43.60 on Jul 6 · $447K Form 4Filing · EDGAR
Mar 5, 202610,250 · ~$354KMar 5, 2026Sold as noticed Sold 10,250 at $33.86 on Mar 5 · $347K Form 4Filing · EDGAR
Dec 5, 202510,250 · ~$419KDec 5, 2025Sold as noticed Sold 10,250 at $40.52 on Dec 5 · $415K Form 4Filing · EDGAR
Sep 4, 202510,250 · ~$252KSep 4, 2025Sold as noticed Sold 10,250 at $23.12 on Sep 4 · $237K Form 4Filing · EDGAR

Every transaction, by company

Each Form 3, 4 and 5 transaction in plain words, newest first.

How these figures work

Values are shares times the price each filing states; grants, exercises and gifts usually state no price. Held after is what the filing reports was held once the transaction was done, directly or through the named holder.

Sionna Therapeutics SION CLO and Head of Program Mgmt. · filings 2025 to 2026 · sold $1.4M · $1.5M noticed on Form 144

DateTransactionSharesPriceValueHeld afterSource
Sep 17, 2026Grant or award from the company+28,13328,133 directFiling · EDGAR
Sep 17, 2026Grant or award from the company+28,13256,265 directFiling · EDGAR
Sep 17, 2026Grant or award from the company
Non-Qualified Stock Option (right to buy)
+103,140103,140 directFiling · EDGAR
Sep 17, 2026Returned to the company
Non-Qualified Stock Option (right to buy)
−103,1400 directFiling · EDGAR
Jul 6, 2026Option or RSU exercised or converted+10,250$6.11$63K10,250 directFiling · EDGAR
Jul 6, 2026Sale under a 10b5-1 plan−10,250$43.60$447K0 directFiling · EDGAR
Jul 6, 2026Option or RSU exercised or converted
Non-Qualified Stock Option (right to buy)
−10,25040,685 directFiling · EDGAR
Mar 5, 2026Option or RSU exercised or converted+10,250$6.11$63K10,250 directFiling · EDGAR
Mar 5, 2026Sale under a 10b5-1 plan−10,250$33.86$347K0 directFiling · EDGAR
Mar 5, 2026Option or RSU exercised or converted
Non-Qualified Stock Option (right to buy)
−10,25050,935 directFiling · EDGAR
Jan 2, 2026Grant or award from the company
Non-Qualified Stock Option (right to buy)
+103,140103,140 directFiling · EDGAR
Dec 5, 2025Option or RSU exercised or converted+10,250$6.11$63K10,250 directFiling · EDGAR
Dec 5, 2025Sale under a 10b5-1 plan−10,250$40.52$415K0 directFiling · EDGAR
Dec 5, 2025Option or RSU exercised or converted
Non-Qualified Stock Option (right to buy)
−10,25061,185 directFiling · EDGAR
Sep 4, 2025Option or RSU exercised or converted+10,250$6.11$63K10,250 directFiling · EDGAR
Sep 4, 2025Sale under a 10b5-1 plan−10,250$23.12$237K0 directFiling · EDGAR
Sep 4, 2025Option or RSU exercised or converted
Non-Qualified Stock Option (right to buy)
−10,25071,435 directFiling · EDGAR
All 11 Forms 3, 4, 5 and 144
FiledFormCompanyLinks
Sep 18, 2026Form 4Sionna Therapeutics SIONFiling · EDGAR
Jul 7, 2026Form 4Sionna Therapeutics SIONFiling · EDGAR
Jul 6, 2026Form 144Sionna Therapeutics SIONFiling · EDGAR
Mar 6, 2026Form 4Sionna Therapeutics SIONFiling · EDGAR
Mar 5, 2026Form 144Sionna Therapeutics SIONFiling · EDGAR
Jan 6, 2026Form 4Sionna Therapeutics SIONFiling · EDGAR
Dec 9, 2025Form 4Sionna Therapeutics SIONFiling · EDGAR
Dec 5, 2025Form 144Sionna Therapeutics SIONFiling · EDGAR
Sep 5, 2025Form 4Sionna Therapeutics SIONFiling · EDGAR
Sep 4, 2025Form 144Sionna Therapeutics SIONFiling · EDGAR
Apr 1, 2025Form 3Sionna Therapeutics SIONFiling · EDGAR

Every figure is as filed with the SEC on Forms 3, 4, 5 and 144. Holdings are the amounts reported after each person's latest filing at each company and can be out of date. Matching a Form 144 notice to Form 4 sales is SEC Tracker's inference from owner, company, dates and share counts, not something the filings state. Not investment advice. Not affiliated with the U.S. SEC.